Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Trastuzumab Emtansine 3.6, Breast Cancer, Second Line

Protocol-ID: 365 V1.1 (Mini), TRASEM3,6, Breast Ca, second-line

Indication(s)

  • Breast Cancer (HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 08.02.2015